A study by the Northwest Minzu University in China has revealed that drinking Coca-Cola and Pepsi can lead to larger testicles and higher testosterone levels.
The university was determining the impact of carbonated beverages on fertility and sexual organs in men.
The study looked at five groups of 30 mice drinking different kinds of beverages for 15 days.
One group drank water, another drank 50 percent Pepsi mixed with tap water, and a third group drank pure Pepsi.
Then a fourth group was given Coke mixed with tap water, and the fifth group drank pure Coke.
The rodents were tested on days one, five, seven, 10, and 15 by weighing their testicles and drawing blood.
The researchers discovered that the mice that drank pure Coca-Cola and Pepsi Cola had higher levels of the male hormone than those that drank water.
Thus, the researchers concluded that drinking Coca-Cola and Pepsi-Cola could promote testis development and enhance testosterone secretion.
They also noted that their findings provide the scientific basis for fully understanding the effects and mechanisms of carbonated beverages on human development and reproductive functions and how they benefit the prevention of prostate dysfunction and cancer.


Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push
Reflection AI Eyes $25 Billion Valuation in Massive $2.5 Billion Funding Round
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
Gold Prices Drop Amid Iran Peace Talk Uncertainty and Stronger Dollar
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Currency Markets Show Caution Amid U.S.-Iran Negotiations
Federal Reserve Balance Sheet Reduction: Brookings Research Outlines Possible Path Forward
Booked to travel through the Middle East? Here’s why you shouldn’t cancel your flight
The Beauty Beneath the Expressway: A Journey from Self to Service 



